Thanks CD.
The timing of the Pharma Partner being announced wasn't discussed, it never is.
The discussion focused on the enormous market potential for an MQC Module under the APAS-PHARMA brand.
For me it doesn't really matter who the MNC Pharma is. Assuming they paid for the proof-of-concept, we wouldn't have heard about it if it were a flop. The cost to develop the MQC Module might be AUD5M; none of the top 10 MNC Pharmas made less than USD12Bn last year. So money is no object. The top 10 is made up of 6 US and 4 EU corporations. The proof of concept used Thermo Fisher media, but this doesn't guarantee the Pharma is US based. If it works, they will all want it.
Estimate number of Bio/Pharmaceutical clean rooms in use today = 11,000. APAS is profitable at 1,000 clinical labs.
GLTAH
Thanks CD.The timing of the Pharma Partner being announced...
Add LBT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $25.45M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.9¢ | $1.627K | 85.61K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 1409999 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 344665 | 5 |
View Market Depth
| Last trade - 15.00pm 06/05/2024 (20 minute delay) ? |
| LBT (ASX) Chart |